Immunotherapy of HPV-associated head and neck cancer: Critical parameters

Various arguments support the development of a vaccine targeting human papillomavirus (HPV) for the treatment of HPV-associated head and neck cancer. However, the mucosal localization of this tumor, the HPV-driven downregulation of MHC Class I molecules and various other immunosuppressive mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizard, Mevyn, Sandoval, Federico, Badoual, Cecile, Pere, Helene, Terme, Magali, Hans, Stephane, Benhamouda, Nadine, Granier, Clemence, Brasnu, Daniel, Tartour, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716751/
https://www.ncbi.nlm.nih.gov/pubmed/23894716
http://dx.doi.org/10.4161/onci.24534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716751/
https://www.ncbi.nlm.nih.gov/pubmed/23894716
http://dx.doi.org/10.4161/onci.24534

Ejemplares similares